NCT04843579 · MORE INFO

Limitations, agreements, and source contact

Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients · Source last updated 2023-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: true

limitations And Caveats

description: The statistical analysis plan (and associated statistical power) was based on an expected sample size of 26 participants. As only 4 participants enrolled, this reduced sample size was not sufficient for the statistical analysis plan as written, and, therefore, only descriptive statistics for the response proportions can be presented for the study.

point Of Contact

email: hyk4001@med.cornell.edu
organization: Weill Cornell Medicine
phone: 646-962-9376
title: Multiple Myeloma Program Manager

Complete source fields

certain Agreement

pi Sponsor Employee: true

limitations And Caveats

description: The statistical analysis plan (and associated statistical power) was based on an expected sample size of 26 participants. As only 4 participants enrolled, this reduced sample size was not sufficient for the statistical analysis plan as written, and, therefore, only descriptive statistics for the response proportions can be presented for the study.

point Of Contact

email: hyk4001@med.cornell.edu
organization: Weill Cornell Medicine
phone: 646-962-9376
title: Multiple Myeloma Program Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice